Evidence mapPaperPMID 19271313Full record

ArticleHearing research2009

Interactions of hearing loss and diabetes mellitus in the middle age CBA/CaJ mouse model of presbycusis.

Olga N Vasilyeva, Susan T Frisina, Xiaoxia Zhu, Joseph P Walton, Robert D Frisina

Open access · greenAbstract read
In one paragraph

Article in Hearing research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Protective Effects of NFrontiers in cellular neuroscience · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. A narrative review of obesity and hearing loss.International journal of obesity (2005) · 2017
    Review
  19. Article
  20. Effects of Long-Term Exercise on Age-Related Hearing Loss in Mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Olga N VasilyevaOtolaryngology Department, University of Rochester Medical School & Dentistry, 601 Elmwood Ave., Rochester, NY 14642-8629, USA.
Susan T Frisina
Xiaoxia Zhu
Joseph P Walton
Robert D Frisina
Rochester Institute of Technology · US

Funding

NEUROIMAGING, AUDIOLOGY, PSYCHOACOUSTICSP01AG009524 · ROCHESTER INSTITUTE OF TECHNOLOGY · 1992 to 2005
$6.8M
CORE--TECHNOLOGY AND COMPUTATIONALP30DC005409 · UNIVERSITY OF ROCHESTER · 2002 to 2005
$1.6M
NIA NIH HHS P01 AG009524NIA NIH HHS P01 AG09524NIDCD NIH HHS P30 DC005409NIDCD NIH HHS P30 DC05409
6 · The paper itself

Abstract

Recently, we characterized the more severe nature of hearing loss in aged Type 2 diabetic human subjects [Frisina, S.T., Mapes, F., Kim, S., Frisina, D.R., Frisina, R.D., 2006. Characterization of hearing loss in aged type II diabetics. Hear. Res. 211, 103-113]. The current study prospectively assessed hearing abilities in middle age CBA/CaJ mice with Type 1 diabetes mellitus (T1DM) (STZ injection) or Type 2 diabetes mellitus (T2DM) (high fat diet), for a period of 6 months. Blood glucose, body weight and auditory tests (Auditory Brainstem Response-ABR, Distortion Product Otoacoustic Emissions-DPOAE) were evaluated at baseline and every 2 months. Tone and broad-band noise-burst responses in the inferior colliculus were obtained at 6 months. Body weights of controls did not change over 6 months (approximately 32 g), but there was a significant (approximately 5 g) decline in the T1DM, while T2DM exhibited approximately 10 g weight gain. Blood glucose levels significantly increased: 3-fold for T1DM, 1.3-fold for T2DM; with no significant changes in controls. ABR threshold elevations were found for both types of diabetes, but were most pronounced in the T2DM, starting as early as 2 months after induction of diabetes. A decline of mean DPOAE amplitudes was observed in both diabetic groups at high frequencies, and for the T2DM at low frequencies. In contrast to ABR thresholds, tone and noise thresholds in the inferior colliculus were lower for both diabetic groups. Induction of diabetes in middle-aged CBA/CaJ mice promotes amplification of age-related peripheral hearing loss which makes it a suitable model for studying the interaction of age-related hearing loss and diabetes. On the other hand, initial results of effects from very high blood glucose level (T1DM) on the auditory midbrain showed disruption of central inhibition, increased response synchrony or enhanced excitation in the inferior colliculus.

Indexed as

AgingAnimalsAuditory ThresholdBlood GlucoseDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Disease Models, AnimalEvoked Potentials, AuditoryEvoked Potentials, Auditory, Brain StemHumansInferior ColliculiMaleMiceMice, Inbred CBAOtoacoustic Emissions, SpontaneousPresbycusisBlood Glucose

Identifiers

PMID19271313
PMCPMC2891295
OpenAlexW2075039068

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.